首页|基于核因子E2相关因子2/血红素加氧酶-1信号通路探讨益气康肺方对脂多糖感染急性肺损伤地鼠氧化损伤的影响

基于核因子E2相关因子2/血红素加氧酶-1信号通路探讨益气康肺方对脂多糖感染急性肺损伤地鼠氧化损伤的影响

扫码查看
目的 基于核因子E2 相关因子 2/血红素加氧酶-1(nuclear factor erythroid-2-related factor2/heme oxygenase1,Nrf2/HO-1)信号通路探讨益气康肺方对脂多糖(lipopolysaccharide,LPS)感染的金黄地鼠肺氧化损伤的影响及其作用机制.方法 将60 只SPF级叙利亚金黄地鼠,随机分为空白组、模型组、地塞米松组、益气康肺方低剂量组、益气康肺方中剂量组、益气康肺方高剂量组,每组雌性5 只,雄性5 只.造模开始前予以预防性给药,空白组和模型组予以等量生理盐水灌胃,地塞米松组于造模前连续腹腔注射地塞米松磷酸钠注射液4 天,益气康肺方低、中、高剂量组于造模前连续灌胃给予相应剂量中药混悬液14 天.预防性给药结束后第2 天,开始LPS气管滴注建立急性肺损伤(acute lung injury,ALI)地鼠模型,造模结束48 小时后解剖取材.BCA法检测肺泡灌洗液蛋白含量水平并计算地鼠肺指数;HE染色检测肺组织病理改变;荧光探针检测活性氧(reactive oxygen species,ROS)含量;TBA法检测丙二醛(malondialdehyde,MDA)含量;WST-1 法检测肺组织超氧化物歧化酶(superoxide dismutase,SOD)活力,比色法检测谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-PX)活力;Western blot法检测肺组织Nrf2、HO-1 蛋白表达水平.结果 与空白组比较,模型组肺指数及BALF中蛋白浓度升高,肺组织病理损伤严重,ROS及MDA水平升高,SOD和GSH-PX活力较低,Nrf2、HO-1 蛋白含量较低.药物干预处理后,与模型组比较,地塞米松和各中药组肺指数及BALF中蛋白浓度较低,肺组织病理损伤轻,ROS及MDA水平低,SOD和GSH-PX活力高,Nrf2、HO-1蛋白含量高,尤以益气康肺方高剂量组疗效最为显著(P<0.05).结论 益气康肺方可能是通过激活Nrf2/HO-1 通路,增强SOD、GSH-PX的活力,抑制LPS引起的炎症和氧化损伤.
Exploration of the effect of Yiqi Kangfei Prescription on oxidative damage in the lungs of golden hamsters with lipopolysaccharide-induced acute lung injury based on the Nrf2/HO-1 signaling path-way
Objective Based on the Nrf2/HO-1 signaling pathway,this study explored the effects and mechanisms of Yiqi Kangfei Prescription on oxidative damage in the lungs of golden hamsters with li-popolysaccharide(LPS)-induced acute lung injury(ALI).Methods Sixty SPF Syrian golden hamsters were randomly divided into blank group,model group,dexamethasone group,low-dose Yiqi Kangfei Prescription group,medium-dose Yiqi Kangfei Prescription group,and high-dose Yiqi Kangfei Prescription group,with 5 females and 5 males in each group.Before modeling,preventive medication was given.Rats in the blank group and the model group were given an equal volume of saline by gavage.Rats in the dexam-ethasone group were given an equal amount of dexamethasone sodium phosphate injection by continuous in-traperitoneal injection for 4 days before modeling.Rats in the low,medium,and high-dose Yiqi Kangfei Prescription groups were given the corresponding doses of traditional Chinese medicine suspension by continuous gavage for 14 days before modeling.Two days after the end of preventive medication,ALI hamster models were established by intratracheal instillation of LPS,and tissues were dissected 48 hours after modeling.The level of the lung lavage fluid(BALF)was detected by the BCA method,and the lung index of hamsters was calculated.The method of HE staining was used to detect pathological changes in lung tissue;fluorescence probes were used to detect ROS levels,the TBA method was used to detect MDA levels,the WST-1 method was used to detect SOD activity in lung tissue,the colorimetric method was used to detect GSH-PX activity,and the method western blotting was used to detect Nrf2 and HO-1 protein expression levels in lung tissue.Results Compared with the blank group,the lung index and protein con-centration in BALF of the model group were increased,lung tissue pathological damage was severe,ROS and MDA levels were elevated,SOD and GSH-PX activities were decreased,and Nrf2 and HO-1 protein content were decreased.After drug intervention,compared with the model group,the lung index and protein concentration in BALF of the dexamethasone and traditional Chinese medicine groups were decreased,lung tissue pathological damage was lighter,ROS and MDA levels were decreased,SOD and GSH-PX activities were increased,and Nrf2 and HO-1 protein content were increased,especially in the traditional Chinese medicine high-dose group,the therapeutic effect was most significant(P<0.05).Conclusion Yiqi Kangfei Prescription may regulate the Nrf2/HO-1 pathway,enhance SOD and GSH-PX activity,and inhibit inflammation and oxidative damage caused by LPS.

acute lung injuryYiqi Kangfei Prescriptionoxidative stressinflammationNrf2/HO-1signaling pathwaylipopolysaccharide

赵秋娟、雷根平、冯喆、王旭钊、何旭恺、张玲

展开 >

712046 咸阳,陕西中医药大学第一临床医学院

临汾市中心医院全科医疗科

急性肺损伤 益气康肺方 氧化应激 炎症 核因子E2相关因子2/血红素加氧酶-1信号通路 脂多糖

广东省黄埔中医药联合创新研究院中医药防治新冠肺炎科研应急攻关专项陕西省重点研发计划重点产业创新链(群)—社会发展领域陕西省中医药管理局关于中医药防治新冠病毒科研攻关专项

2022OTH0052022ZDXM-SF-5ZYJXY-L23004

2024

环球中医药
中华国际医学交流基金会

环球中医药

CSTPCD
影响因子:1.553
ISSN:1674-1749
年,卷(期):2024.17(9)